Evergreening the World’s Most Profitable Medicine

Door 2 juli 2019 januari 24th, 2020 English, Farma, Featured

Foto: Flip Franssen

Even after the expiration of Humira’s patent protection, pharmaceutical company AbbVie almost completely fended off biosimilar competition for this blockbuster medicine in the Netherlands. ‘Their behaviour defies any description.’ By Lucien Hordijk. Read article.